GRANULES INDIA LTD.-$ - 532482 - Shareholding for the Period Ended December 31, 2021
Granules India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here07-01-2022
07-01-2022
Granules India appoints KVS Ram Rao as JMD and CEO
Rao has over two decades of experience in pharmaceuticals and chemical industries04-01-2022
GRANULES INDIA LTD.-$ - 532482 - Board Meeting Outcome for Appointment Of Dr. K.V.S. Ram Rao As Additional Director, Categorized As Executive, On The Board Of The Company.
Appointment of Dr. K.V.S. Ram Rao as Additional Director, categorized as Executive, on the Board of the Company.03-01-2022
Granules India gets USFDA nod for its generic Amphetamine mixed salts
This is for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy30-12-2021
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules Pharmaceuticals, Inc. receives ANDA approval for Amphetamine Mixed Salts (IR Tablets)30-12-2021
Granules India gets USFDA nod for generic Prazosin Hydrochloride capsules
The US Food Drug Administration (USFDA) granted approval to the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI) a wholly owned foreign subsidiary of the company for Prazosin Hydrochloride capsules, of strengths 1mg, 2mg and 5mg, Granules India Limited said in a statement.28-12-2021
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules Pharmaceuticals, Inc., receives ANDA approval for Prazosin Hydrochloride Capsules28-12-2021
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Mrs. Sucharita Rao Palepu as an Additional Director, categorized as Non-Executive Independent on the Board of Granules India Limited.21-12-2021
GRANULES INDIA LTD.-$ - 532482 - Board Meeting Outcome for Appointment Of Dr. Saumen Chakraborty As An Additional Director, Categorized As Non-Executive Independent, On The Board Of The Company
Appointment of Dr. Saumen Chakraborty as an Additional Director, categorized as Non-executive Independent, on the Board of the Company13-12-2021